Literature DB >> 25602931

Multiple myeloma.

Atul Mehta.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25602931     DOI： 10.1179/1024533214Z.000000000333

Source DB:  PubMed          Journal:  Hematology        ISSN： 1024-5332            Impact factor:   2.269


× No keyword cloud information.
  8 in total

1.  Effective examination methods for identifying the primary origins of metastatic bone tumors of unknown primary origin during the initial visit: A retrospective chart review study.

Authors:  Taketsugu Fujibuchi; Hiroshi Imai; Teruki Kidani; Hiromasa Miura
Journal:  SAGE Open Med       Date:  2022-05-24

Review 2.  Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma.

Authors:  Estefanía García-Guerrero; Belén Sierro-Martínez; Jose Antonio Pérez-Simón
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

3.  Multiple Myeloma and Vasculitic Neuropathy: An Unusual Presentation.

Authors:  Nabin Simkhada; Prakash Adhikari; Nisha Baral; Bishal Dhakal; Krish Mahat
Journal:  Cureus       Date:  2021-03-09

4.  Deep Learning-Based CT Imaging in Diagnosing Myeloma and Its Prognosis Evaluation.

Authors:  Jinzhou Wang; Xiangjun Shi; Xingchen Yao; Jie Ren; Xinru Du
Journal:  J Healthc Eng       Date:  2021-09-13       Impact factor: 2.682

5.  Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma.

Authors:  Nancy Y Villa; Masmudur M Rahman; Joseph Mamola; Meaghen E Sharik; Ana Lemos de Matos; Jacquelyn Kilbourne; Kenneth Lowe; Juliane Daggett-Vondras; Julia D'Isabella; Elizabeth Goras; Marta Chesi; P Leif Bergsagel; Grant McFadden
Journal:  Oncotarget       Date:  2022-03-03

6.  Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma.

Authors:  Zhiquan Hao; Siqiao Wang; Zixuan Zheng; Jiehan Li; Wanting Fu; Donglin Han; Yinrou Huang; Qing Lin; Shuyuan Xian; Penghui Yan; Man Li; Ruoyi Lin; Tong Meng; Jie Zhang; Zongqiang Huang
Journal:  Biomed Res Int       Date:  2022-01-27       Impact factor: 3.411

Review 7.  Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma.

Authors:  Annette Gilchrist; Stephanie L Echeverria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-25       Impact factor: 5.555

8.  Hspa13 Promotes Plasma Cell Production and Antibody Secretion.

Authors:  Youdi He; Ruonan Xu; Bing Zhai; Ying Fang; Chunmei Hou; Chen Xing; He Xiao; Guojiang Chen; Xiaoqian Wang; Ning Ma; Gencheng Han; Renxi Wang
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.